- Home
- BRN vs BCTX Comparison
BRN vs BCTX Comparison
Compare BRN & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRN
- BCTX
- Stock Information
- Founded
- BRN 1956
- BCTX 2014
- Country
- BRN United States
- BCTX Canada
- Employees
- BRN N/A
- BCTX N/A
- Industry
- BRN Oil & Gas Production
- BCTX Biotechnology: Pharmaceutical Preparations
- Sector
- BRN Energy
- BCTX Health Care
- Exchange
- BRN Nasdaq
- BCTX Nasdaq
- Market Cap
- BRN 17.6M
- BCTX 15.8M
- IPO Year
- BRN N/A
- BCTX N/A
- Fundamental
- Price
- BRN $1.58
- BCTX $3.50
- Analyst Decision
- BRN
- BCTX Strong Buy
- Analyst Count
- BRN 0
- BCTX 1
- Target Price
- BRN N/A
- BCTX $32.00
- AVG Volume (30 Days)
- BRN 18.6K
- BCTX 40.5K
- Earning Date
- BRN 05-13-2025
- BCTX 03-12-2025
- Dividend Yield
- BRN N/A
- BCTX N/A
- EPS Growth
- BRN N/A
- BCTX N/A
- EPS
- BRN N/A
- BCTX N/A
- Revenue
- BRN $20,046,000.00
- BCTX N/A
- Revenue This Year
- BRN N/A
- BCTX N/A
- Revenue Next Year
- BRN N/A
- BCTX N/A
- P/E Ratio
- BRN N/A
- BCTX N/A
- Revenue Growth
- BRN N/A
- BCTX N/A
- 52 Week Low
- BRN $1.26
- BCTX $0.35
- 52 Week High
- BRN $3.20
- BCTX $7.87
- Technical
- Relative Strength Index (RSI)
- BRN 44.65
- BCTX 44.24
- Support Level
- BRN $1.26
- BCTX $3.44
- Resistance Level
- BRN $1.79
- BCTX $4.36
- Average True Range (ATR)
- BRN 0.08
- BCTX 0.37
- MACD
- BRN -0.01
- BCTX -0.10
- Stochastic Oscillator
- BRN 18.52
- BCTX 11.11
About BRN Barnwell Industries Inc.
Barnwell Industries Inc is an oil and gas firm. Its areas of operations include acquiring, developing, producing, and selling oil and natural gas. The company acquires and develops crude oil and natural gas assets. The company's operating segment includes Oil and natural gas, Contract drilling, Land investment, and Others. It generates maximum revenue from the Oil and natural gas segment. It operates in two geographical segments the United States, which generates a majority of revenue, and Canada.
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.